
InMode Ltd. INMD
€ 11.88
0.0%
Geschäftsbericht 2025
hinzugefügt 04.04.2026
Land |
|
IPO-Jahr |
2019 |
Branche |
Medizinische Geräte |
Börse |
NASDAQ GLOBALSPB |
Anteile |
64.6 M |
Marktkapitalisierung |
$ 886 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Medizinische Geräte"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Bruker Corporation
BRKR
|
$ 36.74 | - | $ 5.47 K | Nasdaq Global Select Market,SPB | ||
|
ClearPoint Neuro
CLPT
|
$ 9.38 | - | $ 266 M | Nasdaq Capital Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.59 | - | $ 36.7 M | Nasdaq Capital Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 12.07 | - | $ 1.63 B | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Delcath Systems
DCTH
|
$ 9.7 | - | $ 347 M | Nasdaq Capital Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.45 | 1.77 % | $ 129 M | Nasdaq Global Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Edwards Lifesciences Corporation
EW
|
$ 81.19 | - | $ 47.5 B | NYSE,SPB | ||
|
FONAR Corporation
FONR
|
$ 18.6 | - | $ 122 M | Nasdaq Capital Market | ||
|
Globus Medical
GMED
|
$ 88.6 | - | $ 12 B | NYSE,SPB | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Helius Medical Technologies
HSDT
|
$ 1.9 | - | $ 1.15 M | Nasdaq Capital Market | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 9.31 | - | $ 717 M | Nasdaq Global Select Market,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 54.14 | - | $ 1.59 B | NYSE,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 1.0 | - | $ 16.9 M | Nasdaq Global Select Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 85.63 | - | $ 2.97 B | NYSE,SPB | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 15.94 | - | $ 374 M | Nasdaq Global Select Market,SPB | ||
|
LENSAR
LNSR
|
$ 5.89 | -2.81 % | $ 70.4 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Medtronic PLC
MDT
|
$ 86.28 | - | $ 111 B | NYSE,SPB | ||
|
Align Technology
ALGN
|
$ 171.87 | - | $ 12.9 B | Nasdaq Global Select Market,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Myomo
MYO
|
$ 0.7 | - | $ 29.3 M | NYSE American | ||
|
AxoGen
AXGN
|
$ 32.64 | - | $ 1.5 B | Nasdaq Capital Market,SPB | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Orthofix Medical
OFIX
|
$ 11.77 | - | $ 466 M | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Penumbra
PEN
|
$ 329.87 | - | $ 12.8 B | NYSE,SPB | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Insulet Corporation
PODD
|
$ 203.5 | - | $ 14.3 B | Nasdaq Global Select Market,SPB | ||
|
Sintx Technologies
SINT
|
$ 2.53 | 0.4 % | $ 7.02 M | Nasdaq Capital Market | ||
|
Butterfly Network
BFLY
|
$ 4.13 | -0.24 % | $ 874 M | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Smith & Nephew plc
SNN
|
$ 32.63 | - | $ 23.8 B | NYSE | ||
|
Stryker Corporation
SYK
|
$ 332.3 | - | $ 127 B | NYSE,SPB | ||
|
Tactile Systems Technology
TCMD
|
$ 24.57 | - | $ 562 M | Nasdaq Global Select Market,SPB | ||
|
TELA Bio
TELA
|
$ 0.63 | 5.47 % | $ 29.6 M | Nasdaq Global Select Market | ||
|
TransMedics Group
TMDX
|
$ 104.8 | - | $ 3.56 B | Nasdaq Global Market | ||
|
Tandem Diabetes Care
TNDM
|
$ 19.17 | - | $ 1.3 B | Nasdaq Global Market,SPB | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market |